Cost-Effectiveness Of Prophylaxis Of Respiratory Syncytial Virus Infection (RSV) With Palivizumab In Preterm Infants In Colombia
May 1, 2013, 00:00
10.1016/j.jval.2013.03.337
https://www.valueinhealthjournal.com/article/S1098-3015(13)00408-7/fulltext
Title :
Cost-Effectiveness Of Prophylaxis Of Respiratory Syncytial Virus Infection (RSV) With Palivizumab In Preterm Infants In Colombia
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)00408-7&doi=10.1016/j.jval.2013.03.337
First page :
A75
Section Title :
Individual's Health
Open access? :
No
Section Order :
1379